Clinical Trial Update: A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis [Phase 3]

View source ↗

Summary

Phase 3 study of BMS-986278 for progressive pulmonary fibrosis is currently active but not recruiting, according to clinical trial updates.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Progressive Pulmonary Fibrosis

Drugs mentioned

• BMS-986278

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Progressive Pulmonary Fibrosis | Phase 3 | Status: ACTIVE_NOT_RECRUITING